Shaanxi Meibang Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 6/6
Shaanxi Meibang Pharmaceutical Group has a total shareholder equity of CN¥1.1B and total debt of CN¥1.0M, which brings its debt-to-equity ratio to 0.09%. Its total assets and total liabilities are CN¥1.7B and CN¥577.8M respectively. Shaanxi Meibang Pharmaceutical Group's EBIT is CN¥59.9M making its interest coverage ratio -13.1. It has cash and short-term investments of CN¥481.2M.
Key information
0.09%
Debt to equity ratio
CN¥1.00m
Debt
Interest coverage ratio | -13.1x |
Cash | CN¥481.17m |
Equity | CN¥1.11b |
Total liabilities | CN¥577.84m |
Total assets | CN¥1.69b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 605033's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥460.9M).
Long Term Liabilities: 605033's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥116.9M).
Debt to Equity History and Analysis
Debt Level: 605033 has more cash than its total debt.
Reducing Debt: 605033's debt to equity ratio has reduced from 9.8% to 0.09% over the past 5 years.
Debt Coverage: 605033's debt is well covered by operating cash flow (33440.6%).
Interest Coverage: 605033 earns more interest than it pays, so coverage of interest payments is not a concern.